Head and Neck Pathology

, Volume 7, Supplement 1, pp 59–67 | Cite as

Low-Grade Salivary Duct Carcinoma or Low-Grade Intraductal Carcinoma? Review of the Literature

Invited Review: An Update on Salivary Gland Pathology


Low-grade salivary duct carcinoma (LG-SDC) is a rare neoplasm characterized by predominant intraductal growth, luminal ductal phenotype, bland microscopic features, and favorable clinical behavior with an appearance reminiscent of florid to atypical ductal hyperplasia to low grade intraductal breast carcinoma. LG-SDC is composed of multiple cysts, cribriform architecture with “Roman Bridges”, “pseudocribriform” proliferations with floppy fenestrations or irregular slits, micropapillae with epithelial tufts, fibrovascular cores, and solid areas. Most of the tumor cells are small to medium sized with pale eosinophilic cytoplasm, and round to oval nuclei, which may contain finely dispersed or dark condensed chromatin. Foci of intermediate to high grade atypia, and invasive carcinoma or micro-invasion have been reported in up to 23 % of cases. The neoplastic cells have a ductal phenotype with coexpression of keratins and S100 protein and are surrounded by a layer of myoepithelial cells in non-invasive cases. The main differential diagnosis of LG-SDC includes cystadenoma, cystadenocarcinoma, sclerosing polycystic adenosis, salivary duct carcinoma in situ/high-grade intraductal carcinoma, and papillary-cystic variant of acinic cell carcinoma. There is no published data supporting the continuous classification of LG-SDC as a variant of cystadenocarcinoma. Given that most LG-SDC are non-invasive neoplasms; the terms “cribriform cystadenocarcinoma” and LG-SDC should be replaced by “low-grade intraductal carcinoma” (LG-IDC) of salivary gland or “low-grade intraductal carcinoma with areas of invasive carcinoma” in those cases with evidence of invasive carcinoma.


Low-grade salivary duct carcinoma Low-grade intraductal carcinoma Cribriform cystadenocarcinoma Salivary duct carcinoma Parotid gland Salivary glands 


  1. 1.
    Delgado R, Klimstra DS, Albores-Saavedra J. Low grade salivary duct carcinoma. A distinctive variant with a low grade histology and a predominant intraductal growth pattern. Cancer. 1996;78:958–67.PubMedCrossRefGoogle Scholar
  2. 2.
    Brandwein-Gensler M, Gnepp DR. Low-grade cribriform cystadenocarcinoma. In: Barnes L, Eveson JW, Reichart P, et al editors. Pathology and Genetics Head and Neck Tumors. Lyon: IARC Press; 2005; 233.Google Scholar
  3. 3.
    Chen KT. Cytology of salivary duct carcinoma. Diagn Cytopathol. 2000;22:132–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Brandwein-Gensler M, Hille J, Wang BY, et al. Low-grade salivary duct carcinoma: description of 16 cases. Am J Surg Pathol. 2004;28:1040–4.PubMedCrossRefGoogle Scholar
  5. 5.
    Kusafuka K, Itoh H, Sugiyama C, et al. Low-grade salivary duct carcinoma of the parotid gland: report of a case with immunohistochemical analysis. Med Mol Morphol. 2010;43:178–84.PubMedCrossRefGoogle Scholar
  6. 6.
    Laco J, Podhola M, Dolezalova H. Low-grade cribriform cystadenocarcinoma of the parotid gland: a neoplasm with favorable prognosis, distinct from salivary duct carcinoma. Int J Surg Pathol. 2010;18:369–73.PubMedGoogle Scholar
  7. 7.
    Arai A, Taki M, Mimaki S, et al. Low-grade cribriform cystadenocarcinoma of the parotid gland: a case report. Auris Nasus Larynx. 2009;36:725–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Nakazawa T, Kondo T, Yuminomochi T, et al. Fine-needle aspiration biopsy of low-grade cribriform cystadenocarcinoma of the salivary gland. Diagn Cytopathol. 2011;39:218–22.PubMedGoogle Scholar
  9. 9.
    Weinreb I. Intraductal carcinoma of salivary gland (so-called low-grade cribriform cystadenocarcinoma) arising in an intra parotid lymph node. Head Neck Pathol. 2011;5:321–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Nakatsuka S, Harada H, Fujiyama H, et al. An invasive adenocarcinoma of the accessory parotid gland: a rare example developing from a low-grade cribriform cystadenocarcinoma? Diagn Pathol. 2011;6:122.PubMedCrossRefGoogle Scholar
  11. 11.
    Khurana KK, Pitman MB, Powers CN, et al. Diagnostic pitfalls of aspiration cytology of salivary duct carcinoma. Cancer. 1997;81:373–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Tatemoto Y, Ohno A, Osaki T. Low malignant intraductal carcinoma on the hard palate: a variant of salivary duct carcinoma? Eur J Cancer B Oral Oncol. 1996;32B:275–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Ide F, Mishima K, Saito I. Circumscribed salivary duct carcinoma of the palate: a non-threatening variant. Histopathology. 2004;45:89–91.PubMedCrossRefGoogle Scholar
  14. 14.
    Weinreb I, Tabanda-Lichauco R, Van der KT, et al. Low-grade intraductal carcinoma of salivary gland: report of 3 cases with marked apocrine differentiation. Am J Surg Pathol. 2006;30:1014–21.PubMedCrossRefGoogle Scholar
  15. 15.
    Weinreb I, Simpson RH, Skalova A, et al. Ductal adenomas of salivary gland showing features of striated duct differentiation (‘striated duct adenoma’): a report of six cases. Histopathology. 2010;57:707–15.PubMedCrossRefGoogle Scholar
  16. 16.
    Weinreb I, Seethala RR, Hunt JL, et al. Intercalated duct lesions of salivary gland: a morphologic spectrum from hyperplasia to adenoma. Am J Surg Pathol. 2009;33:1322–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Foss RD, Ellis GL, Auclair PL. Salivary gland cystadenocarcinomas. A clinicopathologic study of 57 cases. Am J Surg Pathol. 1996;20:1440–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Pollett A, Perez-Ordonez B, Jordan RCK, et al. High-grade papillary cystadenocarcinoma of the tongue. Histopathology. 1997;31:185–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Kobayashi I, Kiyoshima T, Ozeki S, et al. Immunohistochemical and ultrastructural study of a papillary cystadenocarcinoma arising from the sublingual gland. J Oral Pathol Med. 1999;28:282–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Aloudah NM, Raddaoui E, Aldhahri S, et al. Low-grade papillary cystadenocarcinoma of the parotid gland: presentation of a case with cytological, histopathological, and immunohistochemical features and pertinent literature review. Diagn Cytopathol. 2009;37:128–31.PubMedCrossRefGoogle Scholar
  21. 21.
    Johnston NJ, Rose DS, Lutterloch MJ. Cystadenocarcinoma of salivary gland presenting as a cystic lesion in the mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:201–4.PubMedCrossRefGoogle Scholar
  22. 22.
    Kardos TB, Ferguson JW, McMillan MD. Mucus producing adenopapillary carcinoma of the oral cavity. Int J Oral Maxillofac Surg. 1992;21:160–2.PubMedCrossRefGoogle Scholar
  23. 23.
    Notani K, Iizuka T, Yamazaki Y, et al. Mucinous adenocarcinoma of probable minor salivary gland origin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:738–40.PubMedCrossRefGoogle Scholar
  24. 24.
    Yakirevich E, Sabo E, Klorin G, et al. Primary mucin-producing tumors of the salivary glands: a clinicopathological and morphometric study. Histopathology. 2010;57:395–409.PubMedCrossRefGoogle Scholar
  25. 25.
    Danford M, Eveson JW, Flood TR. Papillary cystadenocarcinoma of the sublingual gland presenting as a ranula. Br J Oral Maxillofac Surg. 1992;30:270–2.PubMedCrossRefGoogle Scholar
  26. 26.
    Anderson C, Muller R, Piorkowski R, et al. Intraductal carcinoma of major salivary gland. Cancer. 1992;69:609–14.PubMedCrossRefGoogle Scholar
  27. 27.
    Cheuk W, Miliauskas JR, Chan JK. Intraductal carcinoma of the oral cavity: a case report and a reappraisal of the concept of pure ductal carcinoma in situ in salivary duct carcinoma. Am J Surg Pathol. 2004;28:266–70.PubMedCrossRefGoogle Scholar
  28. 28.
    Chen KT. Intraductal carcinoma of the minor salivary gland. J Laryngol Otol. 1983;97:189–91.PubMedCrossRefGoogle Scholar
  29. 29.
    Simpson RH, Desai S, Di Palma S. Salivary duct carcinoma in situ of the parotid gland. Histopathology. 2008;53:416–25.PubMedCrossRefGoogle Scholar
  30. 30.
    Lewis JE, McKinney BC, Weiland LH, et al. Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases. Cancer. 1996;77:223–30.PubMedCrossRefGoogle Scholar
  31. 31.
    Kapadia SB, Barnes L. Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma. Mod Pathol. 1998;11:1033–8.PubMedGoogle Scholar
  32. 32.
    Chiosea SI, Griffith C, Assaad A, Seethala RR. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma. Am J Surg Pathol. 2012;36:343–50.PubMedCrossRefGoogle Scholar
  33. 33.
    Skalova A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34:599–608.PubMedGoogle Scholar
  34. 34.
    Connor A, Perez-Ordonez B, Shago M, Skalova A, Weinreb I. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am J Surg Pathol. 2012;36:27–34.PubMedCrossRefGoogle Scholar
  35. 35.
    Chiosea SI, Griffith C, Assaad A, Seethala RR. Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands. Histopathology. 2012;61:387–94.PubMedCrossRefGoogle Scholar
  36. 36.
    Fahim L, Weinreb I, Alexander C, Perez Ordonez B. Epithelial proliferation in small ducts of salivary cystadenoma resembling atypical ductal hyperplasia of breast. Head Neck Pathol. 2008;2:213–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Skalova A, Gnepp DR, Simpson RH, Lewis JE, Janssen D, Sima R, et al. Clonal nature of sclerosing polycystic adenosis of salivary glands demonstrated by using the polymorphism of the human androgen receptor (HUMARA) locus as a marker. Am J Surg Pathol. 2006;30:939–44.PubMedCrossRefGoogle Scholar
  38. 38.
    Smith BC, Ellis GL, Slater LJ, Foss RD. Sclerosing polycystic adenosis of major salivary glands. A clinicopathologic analysis of nine cases. Am J Surg Pathol. 1996;20:161–70.PubMedCrossRefGoogle Scholar
  39. 39.
    Gnepp DR. Sclerosing polycystic adenosis of the salivary gland: a lesion that may be associated with dysplasia and carcinoma in situ. Adv Anat Pathol. 2003;10:218–22.PubMedCrossRefGoogle Scholar
  40. 40.
    Gnepp DR, Wang LJ, Brandwein-Gensler M, Slootweg P, Gill M, Hille J. Sclerosing polycystic adenosis of the salivary gland: a report of 16 cases. Am J Surg Pathol. 2006;30:154–64.PubMedCrossRefGoogle Scholar
  41. 41.
    Hui KK, Batsakis JG, Luna MA, et al. Salivary duct adenocarcinoma: a high grade malignancy. J Laryngol Otol. 1986;100:105–14.PubMedCrossRefGoogle Scholar
  42. 42.
    Brandwein MS, Jagirdar J, Patil J, et al. Salivary duct carcinoma (cribriform salivary carcinoma of excretory ducts). A clinicopathologic and immunohistochemical study of 12 cases. Cancer. 1990;65:2307–14.PubMedCrossRefGoogle Scholar
  43. 43.
    Di Palma S, Simpson RH, Marchio C, et al. Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes. Histopathology. 2012;61:629–43.PubMedGoogle Scholar
  44. 44.
    Ihrler S, Sendelhofert A, Weiler C, et al. Preinvasive intraductal neoplasia in salivary adenocarcinoma, not otherwise specified. Virchows Arch. 2006;449:159–63.PubMedCrossRefGoogle Scholar
  45. 45.
    Kleinsasser O, Klein HJ. Hubner G [Salivary duct carcinoma. A group of salivary gland tumors analogous to mammary duct carcinoma]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd. 1968;192:100–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Ying-Ju Kuo
    • 1
  • Ilan Weinreb
    • 2
    • 3
  • Bayardo Perez-Ordonez
    • 2
    • 3
  1. 1.Department of Pathology and Laboratory MedicineTaipei Veterans GeneralTaipeiTaiwan
  2. 2.Department of Pathology, Toronto General HospitalUniversity Health NetworkTorontoCanada
  3. 3.Department of Laboratory Medicine and PathobiologyUniversity of TorontoTorontoCanada

Personalised recommendations